Preventive treatment options that don't involve the use of FVIII or FIX are needed for patients who develop inhibitors, ...

Columnist Jennifer Lynne highlights the emotional and financial strain that many parents face when raising a child with hemophilia.

As his family anticipates moving, columnist Joe MacDonald is relishing the chance he and his wife have to be parents and not caregivers.

A single-center U.S. study found relatively little genetic testing is being done for girls with a 50% risk of being a carrier ...

Note: This column describes the author’s own experiences with factor replacement therapy. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a ...

Aging should be discussed in every bleeding disorders conference, support group, and care plan, writes columnist.

Lately, I’ve been thinking about what it means to be an expert. In my work as a virtual marketer and strategist, the word gets used all the time. People in my profession are expected to act like we ...

Children with severe hemophilia A with blood group O are not at an increased risk of developing FVIII inhibitors, per a study.

Beqvez (fidanacogene elaparvovec-dzkt), a one-time gene therapy developed by Pfizer that was formerly approved for hemophilia B, was found to be safe and effective in reducing bleeding episodes and ...

I recently stumbled across a passage on social media referring to relationships: “If you want a garden? Take care of it. You want love? Love them.” Something about those simple words struck a chord ...